Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 13.140% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a N#Cc1cnc(SCC(=O)N2CCCC2)nc1N
b Cn1c(N)c(C(=O)COC(=O)COc2ccccc2C#N)c(=O)n(C)c1=O
c COc1ccc(S(=O)(=O)N(C)CC(=O)NCCCN2CCOCC2)cc1Cl
d Cc1cc(-c2ccccc2)n2nc(C)c(C#N)c2n1
Answer: a. N#Cc1cnc(SCC(=O)N2CCCC2)nc1N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1cnc(SCC(=O)N2CCCC2)nc1N
N#Cc1cnc(SCC(=O)N2CCCC2)nc1N
4-amino-2-(2-oxo-2-pyrrolidin-1-ylethyl)sulfanylpyrimidine-5-carbonitrile